Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare to Acquire Applied Precision

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has inked an agreement to acquire cellular imaging products firm Applied Precision for an undisclosed sum.

Applied Precision's products, which include high-resolution and super-resolution microscopy instruments, are expected to complement GE Healthcare's In Cell analyzers that are used for high-throughput sub-cellular analysis in cell biology research.

GE Healthcare said that it will retain Applied Precision's facility in Issaquah, Wash.

"The worldwide resources of GE Healthcare will allow us to significantly widen our reach into new markets and provide a stronger support network for our existing customers," Applied Precision CEO Joe Victor said in a statement.

The firms expect to close the deal in the second quarter of this year.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more